Robert A. Holt
- Aging top 0.2%
- Immunology top 1%
- Immune Cell Function and Interaction 13
- Immunotherapy and Immune Responses 11
- Oncology top 1%
- CAR-T cell therapy research 16
- Cancer Immunotherapy and Biomarkers 10
- Molecular Biology top 1%
- Genomics and Phylogenetic Studies 16
- CRISPR and Genetic Engineering 13
- Enzyme Catalysis and Immobilization 11
- RNA and protein synthesis mechanisms 11
- Periodontics top 1%
- Co-authors
- Robin M. WarrenSteven J.M. JonesJamie FreemanMauro CastellarinPeter H. WatsonBrad H. NelsonEmma Allen‐VercoeLisa Dreolini
- Cited by
- AgingImmunologyOncology
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Robert A. Holt
148 papers receiving 9.3k citations
Hit Papers
Peers
Comparison fields: 5 of 183
- Aging 552
- Immunology 2.0k
- Oncology 2.0k
- Molecular Biology 4.9k
- Periodontics 332
Countries citing papers authored by Robert A. Holt
This map shows the geographic impact of Robert A. Holt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Holt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Holt more than expected).
Fields of papers citing papers by Robert A. Holt
This network shows the impact of papers produced by Robert A. Holt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Holt. The network helps show where Robert A. Holt may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert A. Holt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 22 | |
| 2 | 2021 | 11 | |
| 3 | 2020 | 12 | |
| 4 | 2019 | 132 | |
| 5 | 2019 | 20 | |
| 6 | 2018 | 1 | |
| 7 | 2017 | 20 | |
| 8 | 2017 | 12 | |
| 9 | Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survivalbreakdown → | 2014 | 447 |
| 10 | 2013 | 126 | |
| 11 | Fusobacterium nucleatum infection is prevalent in human colorectal carcinomabreakdown → | 2011 | 1480 |
| 12 | 2008 | 32 | |
| 13 | 2008 | 18 | |
| 14 | 2007 | 21 | |
| 15 | 2006 | 140 | |
| 16 | 2005 | 215 | |
| 17 | 2005 | 168 | |
| 18 | 1996 | 28 | |
| 19 | 1996 | 99 | |
| 20 | 1992 | 16 |
About Robert A. Holt
Robert A. Holt is a scholar working on Aging, Immunology, Oncology, Molecular Biology and Genetics, having authored 148 papers that have together received 9.5k indexed citations. Recurring topics across this work include Genomics and Phylogenetic Studies (16 papers), CAR-T cell therapy research (16 papers), CRISPR and Genetic Engineering (13 papers), Immune Cell Function and Interaction (13 papers), Enzyme Catalysis and Immobilization (11 papers), RNA and protein synthesis mechanisms (11 papers), Immunotherapy and Immune Responses (11 papers) and Cancer Immunotherapy and Biomarkers (10 papers). The work is most often cited by research in Aging (552 citations), Immunology (2.0k citations), Oncology (2.0k citations), Molecular Biology (4.9k citations) and Periodontics (332 citations). Robert A. Holt has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Robin M. Warren, Steven J.M. Jones, Jamie Freeman, Mauro Castellarin, Peter H. Watson, Brad H. Nelson, Emma Allen‐Vercoe, Lisa Dreolini, Martin Krzywinski and Richard A. Moore. Their work appears in journals such as BMC Genomics, Genome Research, PLoS ONE, Molecular Therapy — Methods & Clinical Development and Genome Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.